About Javeri Equity Derivatives Mutual Funds IPO Corporate Info Research Contact Us
Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  > SCHEME PROFILE
SCHEME PROFILE      
AMC : Category : Scheme :
Quant Healthcare Fund-Reg(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesDivi's Laboratories Limited9.57036130035.4035
Domestic EquitiesRPG Life Sciences Limited9.283815052934.3439
Domestic EquitiesAster DM Healthcare Limited9.216570516434.0947
Domestic EquitiesIPCA Laboratories Ltd7.421518280027.4547
Domestic EquitiesTorrent Pharmaceuticals Ltd7.31008377527.0422
Domestic EquitiesAlivus Life Sciences7.198224629826.6285
Domestic EquitiesZydus Lifesciences Limited7.019429295125.9672
Domestic EquitiesAurobindo Pharma Limited6.816821730025.2177
Domestic EquitiesReliance Industries Limited6.694219421224.7640
Domestic EquitiesZydus Wellness Ltd5.830412834621.5685
Domestic EquitiesPfizer Ltd5.22104823119.3141
Domestic EquitiesHFCL Limited5.1104239000018.9049
Domestic EquitiesSequent Scientific Limited4.7610134632017.6126
Domestic EquitiesSMS Pharmaceuticals Limited3.807166188614.0836
Domestic EquitiesSuraksha Diagnostic Limited2.38323401368.8163
Total 97.6439 361.2164
Cash & Cash Equivalents and Net AssetsTREPS 02-Apr-2025 DEPO 100.663924582.4560
Cash & Cash Equivalents and Net AssetsNCA-NET CURRENT ASSETS-2.7532 -10.1849
Total -2.0893 -7.7289
Treasury Bills91 Days Treasury Bill 24-Apr-20252.691010000009.9548
Total 2.6910 9.9548
Derivatives-FuturesDr. Reddy's Laboratories Limited 24/04/20251.1646381254.3083
Derivatives-FuturesAurobindo Pharma Limited 24/04/20250.5897187002.1816
Total 1.7543 6.4899
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.